Penn Medicine Healthy Heart
Recruiting · NCT06062394 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Pennsylvania
View the official record on ClinicalTrials.gov →Interventions studied
Penn Med Healthy Heart Program
What this trial is about
To leverage access to patients across the primary care network, EPIC tools for identifying eligible patients, and the Way to Health platform to launch and enroll a program that will be evaluated in a clinical trial that is focused on changing patient behavior and powered to detect differences in improving blood pressure and cholesterol over 6 months for Penn Medicine patients in West/Southwest Philadelphia and Lancaster.
Who can take part
Age range
35 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- On the Penn Medicine Primary Care Service Line registry
- Last 2 Blood Pressure readings with Systolic Blood Pressure \>=140 from any outpatient encounter in the last 12 months AND
- ASCVD dx OR ASCVD risk score ≥10% OR Diabetes dx OR A1c ≥6.5 in last year OR Diabetes registry OR Last LDL ≥190 in past five years AND
- Not on a statinor PCSK9, Inclisiran OR on a Low-intensity/moderate-intensity statin) with LDL \>100
Exclusion criteria
- Patients on PCSK9 inhibitors
- Documented statin allergy/ or intolerance in the EMR
- Pregnancy
- Breast feeding
- Markedly shortened life expectancy including:
- metastatic cancer
- hospice
- End Stage Renal Disease
- Congestive Heart Failure
- Dementia
- Is a non-English speaker requiring a translator
- Patients who do not have a cell phone
Where it is running
1 location listed across 1 US state.
- Penn Medicine - Philadelphia, Pennsylvania, United States